Ikonisys acquires Hospitex International, a world leader in cancer diagnostics
PARIS: Ikonisys SA, a company that specializes in early and accurate cancer detection, announced today that it has entered into an agreement to acquire 100% of Hospitex International, an Italian-based company that provides advanced solutions for thin layer cytology and cancer diagnostics. Under the terms, Ikonisys will complete the acquisition of 100% of Hospitex International…